CN101461903A - Chinese medicinal composition for treating painful swelling of throat and constipation, and preparation method thereof - Google Patents
Chinese medicinal composition for treating painful swelling of throat and constipation, and preparation method thereof Download PDFInfo
- Publication number
- CN101461903A CN101461903A CNA2007101511964A CN200710151196A CN101461903A CN 101461903 A CN101461903 A CN 101461903A CN A2007101511964 A CNA2007101511964 A CN A2007101511964A CN 200710151196 A CN200710151196 A CN 200710151196A CN 101461903 A CN101461903 A CN 101461903A
- Authority
- CN
- China
- Prior art keywords
- radix
- solution
- water
- test
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 64
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 206010010774 Constipation Diseases 0.000 title claims abstract description 17
- 230000008961 swelling Effects 0.000 title claims description 19
- 238000000034 method Methods 0.000 claims abstract description 57
- 239000003814 drug Substances 0.000 claims abstract description 45
- 241000255789 Bombyx mori Species 0.000 claims abstract description 22
- 239000010231 banlangen Substances 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims abstract description 8
- 229940097275 indigo Drugs 0.000 claims abstract description 8
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 160
- 238000012360 testing method Methods 0.000 claims description 160
- 239000000243 solution Substances 0.000 claims description 134
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 132
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 claims description 110
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 76
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 68
- 239000000047 product Substances 0.000 claims description 64
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 claims description 57
- 239000010282 Emodin Substances 0.000 claims description 57
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 claims description 57
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 claims description 57
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 claims description 57
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 claims description 57
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 claims description 57
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 claims description 57
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 claims description 54
- 238000000605 extraction Methods 0.000 claims description 50
- 239000013558 reference substance Substances 0.000 claims description 48
- 239000003292 glue Substances 0.000 claims description 42
- 239000000843 powder Substances 0.000 claims description 40
- 239000000284 extract Substances 0.000 claims description 39
- 239000007788 liquid Substances 0.000 claims description 29
- 239000002904 solvent Substances 0.000 claims description 27
- 241000628997 Flos Species 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 25
- 239000000679 carrageenan Substances 0.000 claims description 24
- 229920001525 carrageenan Polymers 0.000 claims description 24
- 229940113118 carrageenan Drugs 0.000 claims description 24
- 239000011521 glass Substances 0.000 claims description 24
- 239000000341 volatile oil Substances 0.000 claims description 24
- 235000010418 carrageenan Nutrition 0.000 claims description 23
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 23
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 22
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 claims description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 238000003556 assay Methods 0.000 claims description 13
- 238000004809 thin layer chromatography Methods 0.000 claims description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- 239000000741 silica gel Substances 0.000 claims description 12
- 229910002027 silica gel Inorganic materials 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 11
- 239000001103 potassium chloride Substances 0.000 claims description 11
- 235000011164 potassium chloride Nutrition 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 9
- 229940109275 cyclamate Drugs 0.000 claims description 9
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 9
- 238000002481 ethanol extraction Methods 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 238000010998 test method Methods 0.000 claims description 9
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 claims description 8
- 230000002421 anti-septic effect Effects 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 8
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 239000012085 test solution Substances 0.000 claims description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229940074393 chlorogenic acid Drugs 0.000 claims description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 4
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 239000006072 paste Substances 0.000 claims description 4
- 238000009928 pasteurization Methods 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 241000202807 Glycyrrhiza Species 0.000 claims description 3
- 240000007171 Imperata cylindrica Species 0.000 claims description 3
- 241000245240 Lonicera Species 0.000 claims description 3
- 235000014435 Mentha Nutrition 0.000 claims description 3
- 241001072983 Mentha Species 0.000 claims description 3
- 241001530126 Scrophularia Species 0.000 claims description 3
- 235000021050 feed intake Nutrition 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- 238000000079 presaturation Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000001117 sulphuric acid Substances 0.000 claims description 3
- 235000011149 sulphuric acid Nutrition 0.000 claims description 3
- 238000011003 system suitability test Methods 0.000 claims description 3
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 3
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 3
- 235000012141 vanillin Nutrition 0.000 claims description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 2
- 238000002405 diagnostic procedure Methods 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims description 2
- 239000012362 glacial acetic acid Substances 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 201000007100 Pharyngitis Diseases 0.000 abstract description 28
- 208000002193 Pain Diseases 0.000 abstract description 22
- 238000007689 inspection Methods 0.000 abstract description 16
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 15
- 208000016150 acute pharyngitis Diseases 0.000 abstract description 13
- 239000006187 pill Substances 0.000 abstract description 9
- 206010001093 acute tonsillitis Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 206010037660 Pyrexia Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000002552 dosage form Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 240000005001 Paeonia suffruticosa Species 0.000 abstract description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract description 3
- 241000555682 Forsythia x intermedia Species 0.000 abstract description 2
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001547127 Fritillaria cirrhosa Species 0.000 abstract 1
- 241000931143 Gleditsia sinensis Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001106477 Paeoniaceae Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 43
- 239000000499 gel Substances 0.000 description 35
- 241000894006 Bacteria Species 0.000 description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000013642 negative control Substances 0.000 description 14
- 210000003800 pharynx Anatomy 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 13
- 239000003440 toxic substance Substances 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 239000012567 medical material Substances 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 239000002671 adjuvant Substances 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 238000000540 analysis of variance Methods 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000011835 investigation Methods 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229940099352 cholate Drugs 0.000 description 5
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 5
- 239000000084 colloidal system Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 5
- 230000003285 pharmacodynamic effect Effects 0.000 description 5
- 229940023488 pill Drugs 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 210000003026 hypopharynx Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 244000247812 Amorphophallus rivieri Species 0.000 description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 229920002581 Glucomannan Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 229920002752 Konjac Polymers 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 239000000252 konjac Substances 0.000 description 3
- 235000010485 konjac Nutrition 0.000 description 3
- 231100001252 long-term toxicity Toxicity 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000167880 Hirundinidae Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 241001570521 Lonicera periclymenum Species 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 238000009654 indole test Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000001139 pH measurement Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005464 sample preparation method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- -1 tragcanth Polymers 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000321096 Adenoides Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 101100400452 Caenorhabditis elegans map-2 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 238000007445 Chromatographic isolation Methods 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000735432 Hydrastis canadensis Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 101150064138 MAP1 gene Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030094 Odynophagia Diseases 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- UPWPBIUUSLIWAI-UHFFFAOYSA-N [4-(4-aminophenyl)sulfonylphenyl]urea Chemical compound C1=CC(NC(=O)N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 UPWPBIUUSLIWAI-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- JXQGGZBUGUHLEJ-UHFFFAOYSA-N butyl acetate formic acid hydrate Chemical compound O.OC=O.CCCCOC(C)=O JXQGGZBUGUHLEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- UWBXIFCTIZXXLS-UHFFFAOYSA-L disodium;2,3,4,5-tetrachloro-6-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 UWBXIFCTIZXXLS-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940085771 feverall Drugs 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000005679 goldenseal Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- RNQBLUNNAYFBIW-NPULLEENSA-M hexadecyl(trimethyl)azanium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate Chemical compound COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)C RNQBLUNNAYFBIW-NPULLEENSA-M 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229960003138 rose bengal sodium Drugs 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine preparation, and relates to a traditional Chinese medicine composition for treating sore throat and constipation and a preparation method thereof, in particular to a medicament prepared from the raw material medicine with effective components such as silkworm excrement, rhubarb, figwort, Chinese honeylocust fruit, red paeony root, dwarf lilyturf turber, forsythia, radix isatidis, rehmannia, honeysuckle, rhizome imperatae, tree peony bark, natural indigo, fritillaria cirrhosa, mint, and licorice and used for clearing away heat and toxic materials, relieving sore throat and pain, and treating diseases such as sore throat caused by pneumogastric intrinsic heat, fever and fidget, constipation, children acute pharyngitis, acute tonsillitis, and the like and a preparation method thereof. The invention also discloses a recipe for gelata prepared by extracting and mixing sixteen medicinal materials such as silkworm excrement, rhubarb and the like, quality standard, and a quality inspection method. The dosage form has the advantages of convenience for taking and carrying, good mouth feel, and easy acceptance by children, overcomes the defect that pills and tablets are difficult for the children to take, and is remarkably superior to cleaning pills.
Description
Technical field
The invention belongs to the Chinese medicine preparation technical field, particularly relate to and the present invention relates to a kind of heat-clearing and toxic substances removing, relieving sore throat and pain, be used for laryngopharynx swelling and pain due to the accumulated heat in the lung and stomach, fever and irritability, constipation, infantile acute pharyngitis, medicine of illness such as acute tonsillitis and preparation method thereof the invention still further relates to prescription, quality standard and the quality inspection method of this clear pour point depression glue.
Background technology
Acute pharyngitis (acute pharyngitis) is a pharyngeal mucous membrane, and involves under the mucosa and adenoid acute inflammation, often is secondary to after acute rhinitis or the acute tonsil or is the part of upper respiratory tract infection.Also often be the topical manifestations of general disease or be the prodrome of acute infectious disease.Chang Yin suffers from cold, and is overtired, and tobacco and wine excessively wait and cause whole body and the decline of local resistance, and pathogenic microorganism is taken advantage of a weak point and caused primary disease.Malnutrition is suffered from the chronic heart, kidney, joint disease, and life and working environment are not good, often contact high temperature, dust, destructive stimulus gas etc. and all easily suffer from primary disease, and be the inducement of numerous disease.The patient is of all ages, sex, occupation and regional, and all can fall ill the whole year, the winter-spring season pilosity, and people can have morbidity for several times in 1 year, and can cause severe complication.
China's infantile acute pharyngitis prevalence is 0.5-2.0%, report is arranged up to 5.2%, and because of the air pollution reason, the trend of increase is arranged in recent years.Serious harm human physical and mental health, so patient's wide material sources.Pathogenic microorganism is mainly Hemolytic streptococcus, Diplococcus pneumoniae, hemophilus influenzae and virus.Clinical manifestation onset urgency, the pharyngeal drying of first time-out, scorching hot, the pain that continues increase the weight of when swallowing, and can be radiated to ear.Sometimes general malaise, joint aches, headache, inappetence, and in various degree heating is arranged.Body temperature can be increased to 38 ℃, modern medicine is mainly with antibiotics etc., to throat do, itch, symptom such as pain is rapid-action, change the pharyngeal mucosa tissue but can not repair, just normal " curing the symptoms, not the disease " of saying, after being subjected to extraneous virus, antibacterial or chemical stimulation once more, subinfection very easily again.And antibiotic is destructive strong to human tissue cell, and antibiotic also has very strong Drug resistance simultaneously, uses for a long time, repeatedly to produce abortive response.Though antibiotic is obtained certain curative effect, toxicity, side effect is big.As use collutory, and buccal cydiodine, Anji buccal tablet etc., these medicine life-time service can cause the internal environment of oral cavity disorder.
Falling ball clearly is a kind of classical Chinese patent medicine, Ministry of Public Health standard WS
3-B-3679-98 puts down in writing prescription: silkworm excrement, Radix Et Rhizoma Rhei, Indigo Naturalis, Radix Scrophulariae, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Isatidis, Radix Ophiopogonis, Fructus Forsythiae, Cortex Moutan, Radix Rehmanniae, Radix Glycyrrhizae, Rhizoma Imperatae, Flos Lonicerae, Herba Menthae, Bulbus Fritillariae Cirrhosae
Method for making: above ten Six-elements, be ground into fine powder, mixing sieves.Every 100g powder adds to practice sweet 50g~60g and add an amount of water makes small honey pill or big honeyed pills promptly.
Function with cure mainly: heat-clearing and toxic substances removing, relieving sore throat and pain is used for laryngopharynx swelling and pain due to the accumulated heat in the lung and stomach, fever and irritability, constipation, infantile acute pharyngitis, illness such as acute tonsillitis.
Other has applying date 2003.6.4, the patent record prescription of patent No. ZL03129980.6 " heat-clearing and detoxic medicine and preparation method thereof ": silkworm excrement 20.84g Radix Et Rhizoma Rhei 20.84g Indigo Naturalis 10.42g Radix Scrophulariae 20.84g Semen Gleditsiae 20.84g Radix Paeoniae Rubra 20.84g Radix Isatidis 20.84g 20.84g Radix Ophiopogonis Fructus Forsythiae 20.84g Cortex Moutan 13.54g Radix Rehmanniae 20.84g Radix Glycyrrhizae 6.88g goldenseal 20.84g Flos Lonicerae 20.84g Mentholum 0.052g Bulbus Fritillariae Cirrhosae 2.60g
Function with cure mainly: heat-clearing and toxic substances removing, relieving sore throat and pain is used for laryngopharynx swelling and pain due to the accumulated heat in the lung and stomach, fever and irritability, constipation, infantile acute pharyngitis, Qingjiangpian tablets agent medicine of illness such as acute tonsillitis and preparation method thereof.
Ball falls clearly, Qingjiangpian tablets is a kind of pure Chinese medicinal preparation, evident in efficacy, major function is a heat-clearing and toxic substances removing, relieving sore throat and pain, but traditional ball, Qingjiangpian tablets volume of swallowing that falls clearly is big, mouthfeel is poor, absorb not exclusively, bioavailability is not high, particularly is not suitable for the child and swallows, so developing efficient, low toxicity, heat-clearing and toxic substances removing, relieving sore throat and pain is that one is suitable for the preparation that the child swallows, significant.
Summary of the invention
The object of the present invention is to provide a kind of reasonable recipe, select YAOJING good, the bioavailability height, disintegrate is fast, scattered, mouthfeel is suitable, absorbs fully, a kind of heat-clearing and toxic substances removing that is used for of increase evident in efficacy, the quality standard and the quality inspection method of clear pour point depression glue of relieving sore throat and pain and preparation method thereof and this clear pour point depression glue.
To achieve these goals, carried out etiology and pathogenesis method of treatment and compatibility analysis: acute pharyngitis is because exopathogen invasion and attack, injure pharyngeal so that qi depression to blood stasis, institute causes red swelling of the pharynx pain illness through the BI-syndrome involved the blood vessels resistance.With pharyngalgia or odynophagia, pharyngeal red slightly or scarlet, edema, heating, dry pharynx are scorching hot, aversion to cold is main performance.Chang Yin suffers from cold, overtired, tobacco and wine excessively wait and cause whole body and the decline of local resistance, pathogenic microorganism is taken advantage of a weak point and is caused primary disease, malnutrition is suffered from the chronic heart, kidney, joint disease, and life and working environment are not good, often contact high temperature, dust, destructive stimulus gas etc. are all easily suffered from primary disease, and are the inducements of numerous disease.Because pathogenic heat stop up to be contained, steam the throat that burns, so it is acute to have sore throat, the intenseness of heat impairment of body fluid, so thirsty polydipsia, the evil lung gold of violating, lung qi a surname falls not normal, and body fluid fried in shallow oil and be smelt expectorant, stores in the lung key, then cough, the sticking difficulty of expectorant goes out, interior-heat is contained in interior, and be full of in outside, so generate heat.Stomach internal organs intenseness of heat, FU QI being obstructed, thus big dry stool, red tongue, tongue fur BOHUANG, rapid pulse are strong, are all resembling of excess-heat, thus the legislation heat-clearing and toxic substances removing, relieving sore throat and pain.Be intended to drive straight on to latibulum, just middle pathogenesis, pyretic toxicity is clear, the throat profit, pain is ended and is recovered.
Acute pharyngitis traditional Chinese medical science basic pathology is because exopathogen invasion and attack, injure pharyngeal so that qi depression to blood stasis, institute causes red swelling of the pharynx pain through the BI-syndrome involved the blood vessels resistance.We are with silkworm excrement, Radix Et Rhizoma Rhei, Semen Gleditsiae, the fire of the clear eliminating the pathogens from the lung stomach of Rhizoma Imperatae, removing heat by catharsis expells the pathogenic heat.The silkworm excrement expelling wind and removing dampness, regulating the function of the stomach to resolve the turbidity; The Radix Et Rhizoma Rhei poison that purges heat, removing mass stagnates; The Semen Gleditsiae moistening dryness for relaxing bowels, the detumescence of dispeling the wind; The clear eliminating the pathogens from the lung stomach of Rhizoma Imperatae is treated the rotten all cards of the strongly fragrant pharyngalgia of stopping up of lung-heat.Fructus Forsythiae, Radix Isatidis, Indigo Naturalis, Flos Lonicerae heat-clearing and toxic substances removing, saturating flesh induces sweat, and heat clearing away is by wind.Radix Ophiopogonis, Radix Rehmanniae, Radix Paeoniae Rubra, Radix Scrophulariae removing pathogenic heat from blood and toxic substance from the body, nourishing YIN and moistening the lung, reinforcing stomach reg fluid.The Herba Menthae wind-dispelling heat-dissipating is evacuated pathogenic factor in the exterior, Cortex Moutan heat clearing away, removing heat from blood, and promoting the circulation of blood stagnates, and stagnates to go and hot and suffocating explaining by oneself, so also bring down a fever.Bulbus Fritillariae Cirrhosae lung moistening eliminating stagnation, antitussive reduces phlegm.Radix Glycyrrhizae and middle emergency, the pathogenic factor in the exterior that looses, throat, detoxifcation, lung moistening removes the long-pending heat of stomach, coordinating the actions of various ingredients in a prescription.This Fang Qing goes up diarrhea, induce sweat dredge in and based on removing heat by catharsis expells the pathogenic heat, make pyretic toxicity be able to removing summer-heat, heresy has outlet, thereby the throat tonneau.All medicines share, and play heat-clearing and toxic substances removing altogether, and the effect of relieving sore throat and pain is applicable to the caused infantile acute pharyngitis of lung sthenia gastropyrexia.So at the former ball that falls clearly, the medicine that the national drug standards are recorded, the number of recording is: WS
3The suitable consumption proportion of screening changes dosage form on the basis of-B-3680-98, change technology, the formulation standard, studies on acute toxicity, long term toxicity test, Pharmacodynamic test of active extract have been carried out, finally the invention provides a kind of Chinese medicine composition for the treatment of painful swelling of throat and constipation of following technical scheme, it is characterized in that making the raw materials of effective components medicine and consist of:
400 Radix Ophiopogonis 400 of silkworm excrement 400 Radix Et Rhizoma Rhei 400 Radix Scrophulariaes 400 Semen Gleditsiae 400 Radix Paeoniae Rubra
Fructus Forsythiae 400 Radix Isatidis 400 Radix Rehmanniae 400 Flos Loniceraes 400 Rhizoma Imperataes 400
Cortex Moutan 260 Indigo Naturaliss 200 Bulbus Fritillariae Cirrhosaes 200 Herba Menthaes 200 Radix Glycyrrhizaes 132;
Its preparation method is:
More than ten Six-elements, Radix Et Rhizoma Rhei powder is made coarse powder and is mixed with Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, adds 8 times of amount 80% ethanol extractions twice, each 1.5 hours, merge alcohol extract, reclaim ethanol and be condensed into cream, relative density 1.30~11.35,60 ℃;
Cortex Moutan is made coarse powder, mix with silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae, Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae, adding 10 times of water gagings decocts twice, each 1.5 hours, collect volatile oil, the gradation of water extract filters, merging filtrate, be concentrated into relative density 1.05~11.08,60 ℃; , put to room temperature, add ethanol and make that to contain alcohol amount be 70%, standing over night, filter, filtrate recycling ethanol is concentrated into relative density 1.25~11.35,60 ℃, thick paste, make plain sheet or coated tablet or thin membrane coated tablet according to appendix rules of preparations of Chinese Pharmacopoeia version in 2000.
The Chinese medicine composition of described treatment painful swelling of throat and constipation is characterized in that described Chinese medicine composition is a pour point depression glue clearly, and it is prepared from by following processing step:
1) prescription: the water extract 0.703kg of Cortex Moutan, silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae, Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae
The ethanol extract 0.37kg of Radix Et Rhizoma Rhei, Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae
The extraction volatile oil 5.5ml of Fructus Forsythiae, Cortex Moutan, Herba Menthae, Flos Lonicerae
Carrageenan 0.3774kg
Rhizoma amorphophalli powder 0.3774kg
Potassium chloride 0.0943kg
Sucrose 3.774kg
Citric acid 0.0566kg
Cyclamate 0.1132kg
Antiseptic 0.0321kg
Water 58.3kg
2) preparation method: feed intake according to the described raw materials of effective components medicine composition that makes of claim 1:
Radix Et Rhizoma Rhei powder is made coarse powder and is mixed with Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, adds 8 times of amount 80% ethanol extractions twice, and each 1.5 hours, merge alcohol extract, reclaim ethanol and be condensed into cream, relative density 1.30~11.35,60 ℃;
Cortex Moutan is made coarse powder, mix with silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae, Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae, adding 10 times of water gagings decocts twice, each 1.5 hours, collect volatile oil, the gradation of water extract filters, merging filtrate, be concentrated into relative density 1.05~11.08,60 ℃; Put to room temperature, add ethanol and make that to contain alcohol amount be 70%, standing over night filters, and filtrate recycling ethanol is concentrated into relative density 1.25~11.35,, 60 ℃ thick paste,
Water is proposed thick paste, alcohol extraction thick paste, citric acid, potassium chloride, white sugar, cyclamate, antiseptic mixing, add the water stirring and dissolving; With carrageenan, Rhizoma amorphophalli powder aqueous solution mixing, heating for dissolving in 70 ℃ of water-baths, add volatile oil, essence, add water to 64.2Kg, mixing, packing, sealing is behind the pasteurization, promptly.
The clear pour point depression glue that the preparation method of the Chinese medicine composition of described treatment painful swelling of throat and constipation makes is characterized in that every glass contains emodin (C
15H
10O
5), chrysophanol (C
15H
10O
4) total amount must not be less than the quantitative target of 0.50mg.
The clear pour point depression glue that the preparation method of the Chinese medicine composition of described treatment painful swelling of throat and constipation makes is characterized in that being provided with in the quality standard diagnostic test project of emodin in Radix Paeoniae, Radix Scrophulariae, Flos Lonicerae, Indigo Naturalis and the Radix Et Rhizoma Rhei, chrysophanol assay:
(1) identification of test method of wherein set Radix Paeoniae is: get 1 glass of this product, be cut into small pieces, put in the round-bottomed flask, add 100ml methanol, water-bath backflow 30min filters, water bath method, residue add water 40ml makes dissolving, filters, by the AB-8 macroporous resin column, internal diameter 10~112mm, long 100mm, earlier with water 100ml eluting, discard water lotion, reuse 30% alcoholic solution 100ml eluting continues with 70% alcoholic solution 80ml eluting; 30% ethanol elution evaporate to dryness, residue add methanol 2ml makes dissolving, as need testing solution; Other gets the peoniflorin reference substance, adds methanol and makes dissolving, makes the solution that every 1ml contains 1mg, in contrast product solution; Test according to an appendix VIB of Chinese Pharmacopoeia version in 2005 thin layer chromatography, draw above-mentioned two kinds of solution, 5 μ l respectively, put respectively on same silica gel g thin-layer plate, with chloroform: ethyl acetate: methanol: formic acid=45:5:10:0.2 is developing solvent, launch, take out, dry, spray is with 10 ℅ ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of peoniflorin reference substance chromatograph on, show the speckle of same color;
(2) identification of test method of wherein set Radix Scrophulariae is: get 70% ethanol elution of using of discriminating (1), water bath method, residue add methanol 2ml makes dissolving, as need testing solution; Other gets Radix Scrophulariae control medicinal material powder 2g, adds methanol 10ml, soaks 1 hour, and supersound process 15 minutes filters, and filtrate is product solution in contrast; Test according to thin layer chromatography (appendix VIB of Chinese Pharmacopoeia version in 2005), draw above-mentioned two kinds of solution, 3 μ l respectively, put respectively on same silica gel g thin-layer plate, with n-butyl alcohol: glacial acetic acid: water=7:1:2 is developing solvent, and lamellae launches with developing solvent presaturation 15 minutes, take out, dry, spray is with vanillin sulphuric acid test solution, and hot blast blows to clear spot; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
(3) identification of test method of wherein set Flos Lonicerae is: get the need testing solution of discriminating (1), be need testing solution; Other gets the chlorogenic acid reference substance, adds dissolve with methanol, makes the solution that every 1ml contains 1mg, in contrast product solution; Test according to an appendix VIB of Chinese Pharmacopoeia version in 2005 thin layer chromatography, draw above-mentioned two kinds of solution, 5 μ l respectively, put respectively on same silica gel g thin-layer plate, with butyl acetate: formic acid: water=7:2.5:2.5 is developing solvent, launches, take out, dry, put under the uviol lamp 365nm and inspect, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color;
(4) identification of test method of wherein set Indigo Naturalis is: get one glass of this product, shred, put in the round-bottomed flask, add chloroform 20ml, water-bath refluxed 10 minutes, filtered, and filtrate is as need testing solution; Other gets the indirubin reference substance, adds chloroform, makes the solution that every 1ml contains 1mg, in contrast product solution; According to thin layer chromatography test, draw each 5 ~ 10ul of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with toluene: chloroform: acetone=5:4:1 is developing solvent, launches, and takes out, and dries; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of identical redness;
(5) emodin in the wherein set Radix Et Rhizoma Rhei, the method for chrysophanol assay are: according to one one of Chinese Pharmacopoeia version in 2005, and appendix VI D high effective liquid chromatography for measuring,
Chromatographic condition and system suitability test octadecylsilane chemically bonded silica are filler; Methanol: 0.1% phosphoric acid solution=85:15 is a mobile phase; Flow velocity 1.0ml/min; Detect wavelength 254nm; Column temperature is a room temperature; Number of theoretical plate calculates by the emodin peak should be not less than 2000;
Precision takes by weighing emodin respectively, the chrysophanol reference substance is an amount of in the preparation of reference substance solution, makes the solution that every 1ml contains 6 μ g, 10 μ g, promptly;
One glass of this product is got in the preparation of need testing solution, and accurate the title decides, chopping, put in the apparatus,Soxhlet's, added the methanol reflux 3 hours, put cold, be transferred in the 100ml measuring bottle, add methanol and be diluted to scale, shake up, precision is measured 25ml, puts in the flask, flings to solvent and adds 8% hydrochloric acid solution 10ml, supersound process 2 minutes adds chloroform 10ml again, reflux 1 hour, put coldly, put in the separatory funnel, with a small amount of chloroform washing container, incorporate in the separatory funnel, divide and get chloroform layer, acid solution reuse chloroform extraction 3 times, each 10ml, merge chloroform liquid, decompression and solvent recovery is to doing, and residue adds methanol makes dissolving, be transferred in the 10ml measuring bottle, add methanol to scale, shake up, filter, get subsequent filtrate, promptly;
Accurate respectively reference substance solution and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
Carried out the pharmacodynamics test of clear pour point depression glue: the function according to clear pour point depression glue cures mainly, and main pharmacodynamics is studied from the detoxifcation of dispeling the wind, antiinflammatory, analgesic, analgesic activity four aspects.
1. the Detoxication of dispeling the wind
1.1. the extracorporeal antivirus effect test shows that clear pour point depression glue is 46.8TCID in external virus attack amount
50(promptly 10
-3.6In the time of doubly), clear pour point depression glue has the obvious suppression effect to influenza virus FM1.
1.2. bacteriostatic test shows that clear pour point depression glue can obviously reduce the mortality rate of mice lethal dose infection of staphylococcus aureus.It is 15 * 10 through lumbar injection concentration that matched group is tried mice
8Staphylococcus aureus solution 0.5ml/ only, animal is all dead in 48 hours.Clear pour point depression glue is subjected to the injection of examination group mouse peritoneal to be starkly lower than matched group with animal dead number in the dosage staphylococcus aureus solution 48 hours.
2. antiinflammatory action
2.1. 3.2, the clear pour point depression glue of 1.6g/kg xylol induced mice ear swelling has the obvious suppression effect.
2.2. the clear pour point depression glue of 2.2g/kg can suppress the rat carrageenan foot swelling effectively, sustainable 4 hours of action time; 1.1g/kg rat paw edema also has the obvious suppression effect, sustainable 3 hours of action time due to the clear pour point depression glue on Carrageenan; 0.55g/kg rat paw edema also has certain inhibitory action due to the clear pour point depression glue on Carrageenan, but only 1 hour effectively.
2.3. the clear pour point depression glue of 2.2g/kg not only can reduce the volume of inflammatory exudate but also can reduce leukocyte count; 1.1g/kg clear pour point depression glue can reduce the volume of inflammatory exudate, but statistical significance is not obvious, but can obviously reduce leukocyte count.
3. rat fever all has tangible refrigeration function due to the clear pour point depression rubber powder of refrigeration function: the 2.2.1.1g/kg foot couple dry yeast.
4. analgesic activity
But 4.1. 3.2, time of licking metapedes first in the clear pour point depression glue of the 1.6g/kg significant prolongation mice 1min, promptly hot plate induced mice pain there is the obvious suppression effect.
4.2. what 3.2, the clear pour point depression glue of 1.6g/kg can reduce acetic acid induced mice writhing response turns round the body number of times.
Experimental result shows: adopting the test effective dose of mice is 1.6g/kg, is equivalent to 12.5 times of clinical consumption, (child body weight 25kg per capita calculates the dried cream of 1.5993g and adjuvant/cup, 2 times/day, 1 glass/time); Adopting the test effective dose of rat is 1.1g/kg, is equivalent to 8.6 times of clinical consumption, (child body weight 25kg per capita calculates the dried cream of 1.5993g and adjuvant/cup, 2 times/day, 1 glass/time).
Clear pour point depression glue has certain antiviral, antibacterial action; Clear pour point depression glue can effectively suppress leukoplania and swelling, and has the exudation effect, shows that it has significant inhibitory effect to acute inflammation; Clear pour point depression glue has tangible refrigeration function to rat fever due to the dry yeast, and its analgesic activity is also more obvious.This results of pharmacodynamic test has shown that this product has heat-clearing and toxic substances removing, relieving sore throat and pain effect, has certain curative effect to infantile acute pharyngitis, acute tonsillitis.
The acute toxicity test of clear pour point depression glue: test objective: observe in one day at interval that certain hour repeatedly gives the empty stomach mice acute toxic reaction that this product is produced, and record its maximum dosage-feeding.
With maximum administration concentration (0.45g/ml, 45%), maximum dosage 40ml/kg, irritate stomach with 18.18g/kg interval 5h in one day and give the clear pour point depression rubber powder of empty stomach mice end 3 times, observed record dead mouse and body surface situation 14 days, mice shows that all are normal after the administration, none death.The maximum dosage of clear pour point depression glue is about 54.54g/kg, and 426 times (the equal body weight of child is calculated by 25kg) being equivalent to clinical child's consumption every day show that this product toxicity is low, clinical drug safety.
The long term toxicity test of clear pour point depression glue: test objective is observed continuous repeated multiple times and is irritated stomach and give issuable toxic reaction and recovery and development behind the clear pour point depression glue of rat, for human safe dose clinically provides with reference to evidence.
Give the clear pour point depression glue of rat 5,3,1.5g/kg. time (10,6,3g/kg. day) 1 month by irritating 20ml/kg every day stomach for 2 times, the behavior of observation rat outward appearance, ingest, drinking-water situation, body weight gain, blood, liver, kidney, coagulation function and multiple organs and tissues pathology.Through comparing its general performance as a result, blood, liver, kidney, the equal zero difference of coagulation function with matched group.Main organs naked eyes no abnormality seen, pathomorphology inspection do not see obviously, clocklike with the medicine relevant diseases.Convalescent period is observed identical with it every index, with the more equal zero difference of matched group.Conclusion: rat 10g/kg/ day, clear pour point depression glue was equivalent to about 78.16 times of child's consumption every day (by 25 kilograms of calculating of child's body weight per capita).Rat gives clearly for a long time, and pour point depression glue does not have overt toxicity and toxic and side effects generation.
We develop, and the pour point depression colloid is through pharmacodynamics test, acute toxicity test, long term toxicity test clearly, and the result has shown that this product has heat-clearing and toxic substances removing, relieving sore throat and pain effect, has certain curative effect to infantile acute pharyngitis, acute tonsillitis.This dosage form has taking convenience simultaneously, carrying convenience, and mouthfeel is good, and the acceptable advantage of child has overcome the problem of children taking difficulties such as pill and tablet, and this side significantly is better than falling clearly ball.
Key problem in technology of the present invention is the rational proportion of above-mentioned 16 flavor Chinese medicines, and combination traditional and high-new preparation method, the extraction means that in preparation process, adopted, make extremely refinement of drug particles, form particle volume and dwindle several times than pill, be convenient to swallow, compliance is good, help the absorption of human body, and then improve bioavailability medicine.
The specific embodiment
Embodiment 1: the Chinese medicine composition of treatment painful swelling of throat and constipation prepares clear pour point depression glue:
1) preparation prescription:
2) preparation method: feed intake according to the described raw materials of effective components medicine composition that makes of claim 1:
Radix Et Rhizoma Rhei powder is made coarse powder and is mixed with Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, adds 8 times of amount 80% ethanol extractions twice, and each 1.5 hours, merge alcohol extract, reclaim ethanol and be condensed into cream, relative density 1.30~1.35,60 ℃;
Cortex Moutan is made coarse powder, mix with silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae, Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae, adding 10 times of water gagings decocts twice, each 1.5 hours, collect volatile oil, the gradation of water extract filters, merging filtrate, be concentrated into relative density 1.05~1.08,60 ℃; Put to room temperature, add ethanol and make that to contain alcohol amount be 70%, standing over night filters, and filtrate recycling ethanol is concentrated into relative density 1.25~1.35,60 ℃, thick paste,
Water is proposed thick paste, alcohol extraction thick paste, citric acid, potassium chloride, white sugar, cyclamate, antiseptic mixing, add the water stirring and dissolving; With carrageenan, Rhizoma amorphophalli powder aqueous solution mixing, heating for dissolving in 70 ℃ of water-baths, add volatile oil, essence, add water to 64.2Kg, mixing, packing, sealing behind the pasteurization, promptly gets clear pour point depression glue, clear pour point depression glue 17g/ cup, 1.4287g crude drug/cup, clinical each half cup below 3 years old, 3~7 years old each 1 glass, 7~12 years old each 1.5 glasss, be one day twice, be two weeks the course of treatment.
Embodiment 2: clear pour point depression colloid amount standard
[prescription] silkworm excrement 400 Radix Et Rhizoma Rhei 400 Radix Scrophulariaes 400 Semen Gleditsiae 400 Radix Paeoniae Rubra 400 Fructus Forsythiaes, 400 Radix Isatidiss, 400 Radix Ophiopogonis 400 Radix Rehmanniae 400 Flos Loniceraes 400 Rhizoma Imperataes 400 Cortex Moutans 260 Indigo Naturaliss 200 Bulbus Fritillariae Cirrhosaes 200 Herba Menthaes 200 Radix Glycyrrhizaes 132
[method for making] above ten Six-elements, Radix Et Rhizoma Rhei powder become coarse powder to mix with Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, add 8 times of amount 80% ethanol extractions twice, and each 1.5 hours, the merging alcohol extract, recovery ethanol is condensed into cream (relative density 1.30~1.35,60 ℃).The Paeonia suffruticosa corium farinosum becomes coarse powder, with silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae, Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae mixes, adding 10 times of water gagings decocts twice, each 1.5 hours, collect volatile oil, the gradation of water extract filters, and merging filtrate is concentrated into relative density 1.05~11.08 (60 ℃), put to room temperature, add ethanol and make that to contain alcohol amount be 70%, standing over night filters, filtrate recycling ethanol, be concentrated into the thick paste of relative density 1.25~11.35 (60 ℃), with the alcohol extraction thick paste, citric acid, potassium chloride, white sugar, cyclamate mixes, and adds the water stirring and dissolving; With carrageenan, Rhizoma amorphophalli powder aqueous solution mixing, heating for dissolving in 70 ℃ of water-baths, add volatile oil, essence, add water to 64.2Kg, mixing, packing, sealing, promptly.
[character] this product is brown to tan translucent soft solid shape gel, feeble QI perfume (or spice), and it is sweet to distinguish the flavor of.
1 glass of this product is got in [discriminating] (1), is cut into small pieces, and puts in the round-bottomed flask, add 100ml methanol, water-bath backflow 30min filters, water bath method, residue add water 40ml makes dissolving, filters, by AB-8 macroporous resin column (internal diameter 10~112mm, long 100mm), earlier with water 100ml eluting, discard water lotion, reuse 30% alcoholic solution 100ml eluting continues with 70% alcoholic solution 80ml eluting.30% ethanol elution evaporate to dryness, residue add methanol 2ml makes dissolving, as need testing solution.Other gets the peoniflorin reference substance, adds methanol and makes dissolving, makes the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography (appendix VIB of Chinese Pharmacopoeia version in 2005), draw above-mentioned two kinds of solution, 5 μ l respectively, put respectively on same silica gel g thin-layer plate, with chloroform: ethyl acetate: methanol: formic acid (45:5:10:0.2) is developing solvent, launch, take out, dry, spray is with 10 ℅ ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with the corresponding position of peoniflorin reference substance chromatograph on, show the speckle of same color.
(2) get 70% ethanol elution of using of discriminating (1), water bath method, residue add methanol 2ml makes dissolving, as need testing solution.Other gets Radix Scrophulariae control medicinal material powder 2g, adds methanol 10ml, soaks 1 hour, and supersound process 15 minutes filters, and filtrate is product solution in contrast.Test according to thin layer chromatography (appendix VIB of Chinese Pharmacopoeia version in 2005), draw above-mentioned two kinds of solution, 3 μ l respectively, put respectively on same silica gel g thin-layer plate, with n-butyl alcohol-glacial acetic acid-water (7:1:2) is developing solvent, and lamellae launches with developing solvent presaturation 15 minutes, take out, dry, spray is with vanillin sulphuric acid test solution, and hot blast blows to clear spot.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color.
(3) get the need testing solution of discriminating (1), be need testing solution.Other gets the chlorogenic acid reference substance, adds dissolve with methanol, makes the solution that every 1ml contains 1mg, in contrast product solution.According to thin layer chromatography (appendix VIB of Chinese Pharmacopoeia version in 2005) test, draw above-mentioned two kinds of solution, 5 μ l respectively, put respectively on same silica gel g thin-layer plate, with butyl acetate-formic acid-water (7:2.5:2.5) is developing solvent, launches, and takes out, dry, put under the uviol lamp (365nm) and inspect.In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color.
(4) get one glass of this product, shred, put in the round-bottomed flask, add chloroform 20ml, water-bath refluxed 10 minutes, filtered, and filtrate is as need testing solution.Other gets the indirubin reference substance, adds chloroform, makes the solution that every 1ml contains 1mg, in contrast product solution.According to the thin layer chromatography test, draw each 5~10ul of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, be developing solvent with toluene-chloroform-acetone (5:4:1), launch, take out, dry.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of identical redness.
[inspection] pH value is got two glasss of this product, puts in the band plug conical flask, and heating in water bath makes dissolving, under 70 ℃ of water bath heat preservations, measures according to pH value algoscopy (appendix VIIG of Chinese Pharmacopoeia version in 2005), and this product pH should be 5~7.
The limit test of microbe of this product should be up to specification according to microbial limit test (an appendix XIII of Chinese Pharmacopoeia version in 2005 C) inspection.Conventional method is adopted in count of bacteria; Mycete and yeast counting adopt conventional method; The control bacterium is checked and adopts conventional method.
The need testing solution preparation: get this product 10g, put in the conical flask, add the 45 ℃ of aseptic sodium chloride of pH7.0-peptone buffer solution 100ml, jolting makes dissolving in 45 ℃ of water-baths, is the test liquid of 1:10.
Media dilution method: get the test liquid 1ml of 1:10, put respectively by (0.2ml/ ware) in 5 plates
This product should meet under the gel item each relevant miscellaneous stipulations (one one of Chinese Pharmacopoeia version in 2005, appendix IC).
[assay] measured according to high performance liquid chromatography (one one of Chinese Pharmacopoeia version in 2005, appendix VI D).
Chromatographic condition and system suitability test octadecylsilane chemically bonded silica are filler; Methanol-0.1% phosphoric acid solution (85:15) is a mobile phase; Flow velocity 1.0ml/min; Detect wavelength 254nm; Column temperature is a room temperature.Number of theoretical plate calculates by the emodin peak should be not less than 2000.
Precision takes by weighing emodin respectively, the chrysophanol reference substance is an amount of in the preparation of reference substance solution, makes the solution that every 1ml contains 6 μ g, 10 μ g, promptly.
One glass of this product is got in the preparation of need testing solution, and accurate the title decides, chopping, put in the apparatus,Soxhlet's, added the methanol reflux 3 hours, put cold, be transferred in the 100ml measuring bottle, add methanol and be diluted to scale, shake up, precision is measured 25ml, puts in the flask, flings to solvent and adds 8% hydrochloric acid solution 10ml, supersound process 2 minutes adds chloroform 10ml again, reflux 1 hour, put coldly, put in the separatory funnel, with a small amount of chloroform washing container, incorporate in the separatory funnel, divide and get chloroform layer, acid solution reuse chloroform extraction 3 times, each 10ml, merge chloroform liquid, decompression and solvent recovery is to doing, and residue adds methanol makes dissolving, be transferred in the 10ml measuring bottle, add methanol to scale, shake up, filter, get subsequent filtrate, promptly.
Accurate respectively reference substance solution and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
This product contains emodin (C for every glass
15H
10O
5), chrysophanol (C
15H
10O
4) total amount must not be less than 0.50mg.
[function with cure mainly] heat-clearing and toxic substances removing, relieving sore throat and pain.Be used for laryngopharynx swelling and pain due to the accumulated heat in the lung and stomach card, it is fidgety to generate heat, constipation.Infantile acute pharyngitis, acute tonsillitis see above patient.
[usage and consumption] is oral, children's below 3 years old, each oral 0.5 glass of children's below 3 years old, children's was each oral 1 glass in 3 years old~7 years old, 7 years old~12 years old each oral 1.5 glasss, 2 times on the one.
[specification] every glass of content 17g.
Shady and cool place is put in [storage] sealing.
Embodiment 3: the quality standard draft of clear pour point depression glue is drafted explanation
This product is by ten Six-element medical materials such as Bombyx mori L., the Radix Et Rhizoma Rhei gel through extracting, mix, making respectively.Now relevant issues in the clear pour point depression colloid amount draft standard are described as follows:
The gel gel is gel under this standard [character] item, behind the disengaging packing container, can keep original form substantially, and tissue is soft moderate, high resilience, and exquisiteness, even does not have obvious floccule.
This standard [discriminating] item down
(1) the thin layer discrimination test of Radix Paeoniae Rubra in the side of being is a reference substance with the peoniflorin, makes the negative sample that lacks Radix Paeoniae Rubra in the prescription ratio, presses the operation of need testing solution preparation method, makes negative controls.The test sample preparation method adopts methanol directly to extract, and disturbs very greatly, does not see the peoniflorin speckle, adopts the macroporous adsorbent resin processing then to reach Expected Results.And 30% extracting solution can be used as the test sample that Flos Lonicerae is differentiated simultaneously; 70% eluent can be used as the test sample that Radix Scrophulariae is differentiated.By text manipulation, in the test sample chromatograph, with the corresponding position of reference substance chromatograph on show the bluish violet speckle of same color, though the negative control product also have a speckle, be yellow spotting, this discriminating identification that is positive.
(2) the thin layer discrimination test of Radix Scrophulariae in the side of being is a reference substance with the Radix Scrophulariae control medicinal material, makes the negative sample that lacks Radix Scrophulariae in the prescription ratio, presses the operation of need testing solution preparation method, makes negative controls.By text manipulation, the Radix Scrophulariae control medicinal material has two red principal spots, in the test sample chromatograph, with the corresponding position of first principal spot of Radix Scrophulariae control medicinal material chromatograph on show the punctation of same color, the identification that is positive of the no corresponding speckle of negative control product, this discriminating.
(3) the thin layer discrimination test of Flos Lonicerae in the side of being is a reference substance with the chlorogenic acid, makes the negative sample that lacks Flos Lonicerae in the prescription ratio, presses the operation of need testing solution preparation method, makes negative controls.By text manipulation, in the test sample chromatograph, with the corresponding position of reference substance chromatograph on show the fluorescence speckle of same color, the no corresponding speckle of negative control product, this discriminating identification that is positive.See photo 3.
(4) the thin layer discrimination test of Indigo Naturalis in the side of being is a reference substance with the indirubin.Contain indirubin, indigo in the Indigo Naturalis, indigo in 80% ethanol extraction have, and indigo and indirubin relatively measures lowlyer, so and indigo instability is selection indirubin product in contrast.Make the negative sample that lacks Indigo Naturalis in the prescription ratio, press the operation of need testing solution preparation method, make negative controls.By text manipulation, in the test sample chromatograph, with the corresponding position of reference substance chromatograph on show the speckle of same color, the no corresponding speckle of negative control product.If Development of Thin-Layer Chromatography is undesirable, yellow spotting meeting determining interference, though through changing development system, effect is undesirable.After placing half an hour, the aubergine speckle of indirubin can be more clear.[inspection] 1, pH get two glasss of this product, put in the band plug conical flask, and heating in water bath makes dissolving, under 70 ℃ of water bath heat preservations, measures according to pH value algoscopy (appendix VIIG of Chinese Pharmacopoeia version in 2005), measures the pH of three batch samples, the results are shown in Table 1.
Table 1 PH measurement result
Lot number | 060401 | 060402 | 060403 |
pH | 6.3 | 6.2 | 6.2 |
According to three batch sample pH measurement results, regulation this product this product pH should be 5~7.
2, content uniformity: according to (one one of Chinese Pharmacopoeia version in 2005, appendix IQ) regulation under the gel item, according to one one of Chinese Pharmacopoeia version in 2005, appendix XIIC minimum fill inspection technique is measured the loading amount of three batch samples.Every glass of labelled amount 17g of this product, average loading amount is no less than the sign loading amount, and each container loading amount is no less than 93% of sign loading amount.The results are shown in Table 2.
The inspection of table 2 content uniformity
Lot number | 060401 | 060402 | 060403 |
1 | 17.0567 | 16.8879 | 16.7867 |
2 | 17.3524 | 16.6787 | 17.1545 |
3 | 17.2345 | 16.6545 | 16.2332 |
4 | 17.7867 | 16.5687 | 16.5845 |
5 | 17.4512 | 17.5645 | 17.1243 |
6 | 17.0124 | 16.9786 | 16.4989 |
7 | 17.3131 | 16.5634 | 17.0676 |
8 | 17.2367 | 16..4334 | 16.8524 |
9 | 17.3465 | 17.2341 | 17.0945 |
10 | 17.4323 | 17.5678 | 17.3687 |
Average loading amount | 17.3223 | 16.9132 | 16.8765 |
The result shows that this product content uniformity meets the pertinent regulations of pharmacopeia appendix XIIC minimum fill inspection technique.3, limit test of microbe: this product limit test of microbe method validation test basis " Chinese Pharmacopoeia version in 2005 " limit test of microbe method is checked.
(1) lot number: 060401,060402,060403
(2) instrument: Roberval's balance; The IV mycete is cultivated; SKP-01 electro-heating standing-temperature cultivator DSHZ-300A; The constant temperature water bath agitator
(3) culture medium: nutrient broth medium, improvement Martin culture medium, nutrient agar, Rose Bengal Sodium culture medium, cholate lactose medium, 4-methyl umbelliferone heteroside culture medium (MUG), mannitol sodium chloride agar culture medium, pH7.0 sodium chloride peptone buffer agent, 0.9% sodium chloride solution, indole test solution.Cholate lactose fermentation culture medium, EMB agar.Four sulfacid sodium viride nitens culture medium, cholate sulfur breast agar culture medium.
(4) checking of antibacterial, mycete and yeast method of counting: checking strain: escherichia coli [CMCC (B) 44102]; Bacillus subtilis [CMCC (B) 63501]; Staphylococcus aureus [CMCC (B) 26003]; Candida albicans [CMCC (F) 98001]; Aspergillus niger [CMCC (F) 98003] (inspection institute in deriving from)
The preparation of bacterium liquid: staphylococcus aureus, escherichia coli and the bacillus subtilis meat soup liquid culture 2-3 oese of cultivating 18~24 hours of learning from else's experience 35 ℃ adds in the 9ml0.9% sodium chloride solution, and 10 times are diluted to 10
-4~10
-8Be about 50~100cfu/ml, it is standby to do the viable bacteria counting.
The Candida albicans liquid culture of learning from else's experience 25 ℃ and cultivating 18 ~ 24 hours, the 2-3 oese adds in the 9ml0.9% sodium chloride solution, and 10 times are diluted to 10
-4~10
-8Be about 50~100cfu/ml, it is standby to do the viable bacteria counting.
Learn from else's experience and cultivate the aspergillus niger slant culture in a week, add 0.9% sodium chloride solution 3ml, wash mycotic spore, get 0.1ml and add in the 9ml0.9% sodium chloride solution, 10 times are diluted to 10
-5~10
-8Be about 50~100cfu/ml, it is standby to do the viable bacteria counting.
Operational approach: test liquid preparation: get this product 10g, put in the conical flask, add the 45 ℃ of aseptic sodium chloride of pH7.0-peptone buffer agent 100ml, jolting makes moltenly in 45 ℃ of water-baths, is the test liquid of 1:10.
Determination of recovery rates: (1) bacterium liquid group: get bacterium liquid 1ml respectively, adopt conventional method to prepare plate and pour into corresponding culture medium respectively, after waiting to solidify, put set point of temperature and cultivated 24-72 hour, observed result and counting the results are shown in Table 1.
(2) test sample matched group: get test liquid 1ml, respectively by bacterium liquid group of methods, measure the bacterium number of test sample background, measurement result sees Table 1.
(3) test group: get test liquid 1ml, operate with method by the test sample matched group, each plate adds the corresponding test organisms 1ml of 50~100cfu simultaneously, pours into culture medium immediately, after waiting to solidify, puts set point of temperature and cultivates 24-72 hour, observed result and counting.The results are shown in Table 3.
Table 3 limit test of microbe method validation result
Strain | Escherichia coli | Bacillus subtilis | Staphylococcus aureus | Candida albicans | Aspergillus niger |
Algebraically | 3 | 3 | 3 | 3 | 3 |
Dilution level 10 -n | 6 | 6 | 7 | 5 | 5 |
Bacterium liquid group (CFU/ml) | 88 | 69 | 90 | 89 | 87 |
Test group (CFU/ml) | 73 | 60 | 79 | 86 | 80 |
Test sample group (CFU/ml) | 0 | 0 | 0 | 0 | 0 |
The response rate (%) | 83 | 87 | 88 | 97 | 92 |
As can be known from the above table, the response rate of antibacterial is all greater than 70%, and the response rate of fungus can adopt the conventional method counting also all greater than 70%.
(5) the control bacterium is checked: control the demonstration test of bacterium according to " Chinese Pharmacopoeia version in 2005 " microbial limit test demonstration test.
The preparation of bacterium liquid: the fresh cultured thing of inoculation escherichia coli, staphylococcus aureus is to the 10ml nutrient broth medium, cultivated 18~24 hours in 35~37 ℃, get this culture fluid 1ml and add 0.9% aseptic sodium chloride solution 9ml, adopt 10 times and increase progressively dilution method, make the bacterium number be about the bacteria suspension of 10~100cfu/ml.
Escherichia coli: the preparation of test liquid: with the preparation of test liquid under the above-mentioned operational approach item.
Verification method: test group: escherichia coli is got test liquid 10ml, add among the cholate lactose medium 100ml, as the test sample group, repeat 2 parts again, wherein 1 part adds escherichia coli 10-100 as test group, in addition the diluent of 1 part of adding and test liquid equivalent is as negative control group, cultivated 18~24 hours for 35~37 ℃, get above-mentioned culture fluid 0.2ml, adding contains in 4-methyl umbelliferone heteroside culture medium (MUG) test tube of 5ml, cultivated 5~24 hours in 35~37 ℃, observed result is after the observation, along several indole test solutions of tube wall adding of culture tube, observed result sees Table 2.
The negative bacterium matched group: other gets cholate lactose medium 100ml, operates with method by test group, adds staphylococcus aureus 10-100 as negative control bacterium group, and in 35~37 ℃ of cultivations 18~24 hours, below operation and the same method of test group the results are shown in Table 4.
Table 4 escherichia coli inspection [CMCC (B) 44102]
Add the bacterium amount | BL | MUG | I | The high salt of mannitol | EMB | Gram's staining | Lac | IMViC | The result | |
Test sample | Mix | — | — | — | ||||||
Test group | 88 | Aerogenesis | + | + | + | |||||
Negative control bacterium group | 90 | Mix | — | — | — | — | ||||
Negative control | Clearly | — |
(6) conclusion:, determine that conventional method is adopted in the count of bacteria of the limit test of microbe of this product according to above-mentioned demonstration test result; Mycete and yeast counting adopt conventional method; The control bacterium is checked and adopts conventional method.4, heavy metal, arsenic salt are checked: three batches each one glass of this product is got in (1) heavy metal inspection, press one one of Chinese Pharmacopoeia version in 2005, appendix IX E " heavy metal inspection technique " second method detection this product content of beary metal down.
The result: this product content of beary metal is lower than 10/1000000ths, meets the pharmacopeia regulation, so exclude text.(2) each one glass of three batches of this product is got in the inspection of arsenic salt, press one one of Chinese Pharmacopoeia version in 2005, appendix IX F " arsenic salt inspection technique " first method (ancient Cai Shi method) detection arsenic salt content down.The result: the arsenic salt content is lower than 2/1000000ths, meets the pharmacopeia regulation, so exclude text.
The content assaying method of emodin, chrysophanol in the Radix Et Rhizoma Rhei in this standard [assay] following system side.Measure 5 kinds of compositions altogether, emodin, chrysophanol, chrysophanic acid, physcione, aloe-emodin under a Radix Et Rhizoma Rhei assay of Chinese Pharmacopoeia version in 20005 item.Emodin, chrysophanol are that two kinds of content are the highest, and the chromatographic isolation degree is good, and the normal composition of surveying of various preparation, so this product assay item selects emodin, chrysophanol to measure.With reference to method under a Radix Et Rhizoma Rhei assay of Chinese Pharmacopoeia version in 20005 item, emphasis is investigated the influence factor of the preparation of need testing solution.
1, instrument and reagent LC-10ATvp high performance liquid chromatograph; Chromatographic work station, Zhejiang University's intelligent information Graduate School of Engineering; Emodin, chrysophanol (for assay usefulness, crowd 0737-200511) Nat'l Pharmaceutical ﹠ Biological Products Control Institute; Agents useful for same is chromatographically pure or analytical pure.
2, maximum wavelength is chosen in the mensuration of in 200~400nm scope reference substance solution being carried out uv absorption, and the result shows that emodin, chrysophanol have absorption maximum at the 254nm place.So determine that detecting wavelength is 254nm, identical with pharmacopeia mensuration wavelength.The emodin chrysophanol assay ultra-violet absorption spectrum spectrogram source map 1 that sees reference.
3, the selection official method mobile phase of chromatographic condition is methanol-0.1% phosphoric acid solution (85:5), and this product test sample separating degree is fine, and analysis time is moderate, so mobile phase is defined as methanol-0.1% phosphoric acid solution (85:15).Source map 2 sees reference.
4, the investigation of need testing solution preparation method: a Radix Et Rhizoma Rhei assay of Chinese Pharmacopoeia version in 2005 test sample preparation method, adopt methanol eddy to extract hydrochloric acid hydrolysis, the preparation route of chloroform extraction hydrolyzed solution.Because this product is a compound preparation, and is complete for making methanol extraction, adopt Soxhlet reflux, extract, method, still select to measure free and bonded emodin, chrysophanol content, so continue to use the preparation route of hydrochloric acid hydrolysis, chloroform extraction.The dosage of high spot reviews hydrochloric acid and the quantity of solvent of chloroform extraction.
The same text of the preparation of reference substance solution.
Other flavor medical materials of removing Radix Et Rhizoma Rhei are got in the preparation of negative need testing solution, reach the operation of need testing solution preparation method down by the method for making item, make negative controls.Clear pour point depression glue test sample, reference substance, negative control product and methanol high performance liquid chromatography spectrogram.
5, linear relationship is investigated
Accurate respectively emodin, chrysophanol reference substance solution (the emodin 5.187 μ g/ml of injecting, chrysophanol 9.811 μ g/ml) 2.5,5.0,7.5,10.0,15.0,20 μ l, mensuration is abscissa with injection amount (μ g), the peak area integrated value is a vertical coordinate, draw emodin, chrysophanol standard curve, emodin, chrysophanol standard curve the results are shown in Table 5.
Table 5 emodin, chrysophanol standard curve result of the test
Annotate sample volume (μ l) | Emodin injection amount (* 10 -3μg) | The emodin integrated value | Chrysophanol injection amount (* 10 -3μg) | The chrysophanol integrated value |
2.5 | 14.5245 | 33387.199 | 24.5275 | 69667.203 |
5 | 29.0850 | 63952.000 | 49.0550 | 141971.203 |
7.5 | 43.6275 | 96404.797 | 73.5825 | 217366.406 |
10 | 58.1700 | 128969.602 | 98.1100 | 284448.000 |
15 | 87.2550 | 200729.594 | 147.165 | 433475.188 |
20 | 116.3400 | 265404.813 | 196.2200 | 571190.375 |
Emodin regression equation Y=-2378.998+2301756.551X, r=0.9997, emodin is good linear relationship between 0.015~0.116 μ g.
Chrysophanol regression equation Y=-870.638+2927568.042X, r=0.9999, chrysophanol is good linear relationship between 0.025 ~ 0.196 μ g.
6, solution stability testing result: get same need testing solution, measure once every 2 hours according to the text method, measure after 8 hours, measured once in 24 hours again, result of the test sees Table 6.
Table 6 stability test result
Minute (hour) | The emodin integrated value | The chrysophanol integrated value |
0 | 145430.406 | 339955.188 |
2 | 145904.000 | 343692.813 |
4 | 144864.000 | 347360.000 |
6 | 147324.797 | 346416.000 |
8 | 149588.406 | 351395.188 |
24 | 143072.000 | 328614.406 |
Meansigma methods | 146030.602 | 342905.599 |
RSD(%) | 1.5 | 2.3 |
The result shows that sample is stable in 24 hours.
7, precision test: get same need testing solution, repeat to annotate sample 6 times, the results are shown in Table 7.
8, repeatability test: according to the text method, same lot number sample is carried out 6 times measure, the results are shown in Table 8.The result shows that this law repeatability is good
Table 7 Precision test result
The test sequence number | The emodin integrated value | The chrysophanol integrated value |
1 | 152668.797 | 356396.813 |
2 | 146844.797 | 333456.000 |
3 | 152150.406 | 342995.188 |
4 | 152851.203 | 338630.406 |
5 | 157379.203 | 347680.000 |
6 | 148982.406 | 347641.594 |
Meansigma methods | 151812.802 | 344466.667 |
RSD(%) | 2.4 | 2.3 |
Table 8 reproducible test results
The test sequence number | Emodin content (mg/ cup) | Chrysophanol content (mg/ cup) |
1 | 0.270 | 0.520 |
2 | 0.266 | 0.538 |
3 | 0.272 | 0.505 |
4 | 0.260 | 0.520 |
5 | 0.263 | 0.532 |
6 | 0.274 | 0.500 |
Meansigma methods | 0.268 | 0.519 |
RSD(%) | 2.0 | 2.8 |
9, accuracy test: adopt the application of sample absorption method.
Need testing solution preparation: get known content this product (emodin 0.228mg/ cup, chrysophanol 0.456mg/ cup) 1 glass, the accurate title, decide, accurate respectively emodin, chrysophanol reference substance methanol solution 1ml, the 0.9ml (every ml contains emodin 0.240mg, chrysophanol 0.450mg respectively) of adding, press the operation of need testing solution preparation method, make the accuracy test need testing solution, test sample sample introduction 5 μ l, reference substance sample introduction 10 μ l.Measure according to the text method, emodin, chrysophanol accuracy test the results are shown in Table 9,10.
Table 9 emodin accuracy test result
The test sequence number | Sampling amount (g) | Amount in the test sample (mg) | Reference substance addition (mg) | Measurement result (mg) | The response rate (%) | RSD (%) |
1 | 17.5928 | 0.236 | 0.240 | 0.476 | 100.0 | |
2 | 17.4521 | 0.234 | 0.240 | 0.469 | 97.9 | |
3 | 17.6254 | 0.236 | 0.240 | 0.470 | 97.5 | 1.5 |
4 | 16.2513 | 0.218 | 0.216 | 0.425 | 95.8 | |
5 | 16.7529 | 0.225 | 0.216 | 0.433 | 96.3 | |
6 | 16.6512 | 0.223 | 0.216 | 0.433 | 97.2 |
10, sample size is measured: press three batches of text method working samples, the results are shown in Table 11.
According to the measurement result of three batch samples, consider the fluctuation of different batches medical material content in the production, average 80% for limit, tentative every glass of total amount that contains emodin, chrysophanol of this product is no less than 0.50mg.
Table 10 chrysophanol accuracy test result
The test sequence number | Sampling amount (g) | Amount in the test sample (mg) | Reference substance addition (mg) | Measurement result (mg) | The response rate (%) | RSD (%) |
1 | 17.5928 | 0.472 | 0.450 | 0.921 | 99.9 | |
2 | 17.4521 | 0.468 | 0.450 | 0.901 | 96.2 | |
3 | 17.6254 | 0.473 | 0.450 | 0.913 | 97.8 | 1.9 |
4 | 16.2513 | 0.436 | 0.405 | 0.834 | 98.3 | |
5 | 16.7529 | 0.449 | 0.405 | 0.837 | 95.8 | |
6 | 16.6512 | 0.447 | 0.405 | 0.853 | 100.2 |
Emodin, chrysophanol assay result in table 11 sample
The sample lot number | Emodin content (mg/ cup) | Chrysophanol content (mg/ cup) | Emodin, chrysophanol total amount (mg/ cup) |
060401 | 0.23 | 0.46 | 0.69 |
060402 | 0.27 | 0.52 | 0.79 |
060403 | 0.20 | 0.38 | 0.58 |
Average content | 0.23 | 0.45 | 0.68 |
Embodiment 4: the process study data:
One, dosage form selection: falling the ball method for making clearly is after ten Six-element pulverizing medicinal materials such as Bombyx mori L. become fine powder, to add refined honey and water and make water-honeyed pill or big honeyed pills.Because falling ball clearly is children, the pill bitter in the mouth, and dose is bigger, the children taking difficulty.Gel is that gel is a kind of food of child's popular welcome, and we will fall ball clearly and change over pour point depression glue clearly, preparation high resilience, tasty and refreshing, and the child likes taking, and can effectively bring into play curative effect of medication.Close according to gel (acetaminophen gel (97) is defended the accurate word X-of medicine No. 62, and oral, Jiangsu is with safe pharmaceutcal corporation, Ltd) with the existing that of veriety at present and go on the market.
Two, Study on extraction:
(1) evaluation of medical material and pre-treatment: ten Six-element medical materials all should meet corresponding pertinent regulations under each medical material item of Chinese Pharmacopoeia version in 20005 in the prescription except that Semen Gleditsiae.Radix Et Rhizoma Rhei, Cortex Moutan powder respectively become coarse powder.
(2) extraction process design: gel is meant the semi-solid or thick back liquid preparation with gelation that medicinal substances extract and an amount of substrate are made, so this product Chinese crude drug need extract, uses after making extract.
Contain volatile oil in Fructus Forsythiae, Cortex Moutan, Herba Menthae, the Flos Lonicerae in the prescription, carry out the decocting extraction, collect volatile oil simultaneously so technological design is above-mentioned four flavors and Bombyx mori L., Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Radix Isatidis, Radix Rehmanniae, Radix Glycyrrhizae, Rhizoma Imperatae.Radix Et Rhizoma Rhei, Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae adopt alcohol extraction technology according to the physicochemical property that it contains effective composition.
(3) extraction process technology Study on Conditions:
1. the investigation of the extraction process time of volatile oil:,, should carry out the extraction of volatile oil with reference to pertinent literature according to chemical constituent contained in Fructus Forsythiae, Cortex Moutan, Herba Menthae, the Chinese medicine honeysuckle.Method is as follows:
Get recipe quantity Fructus Forsythiae, Cortex Moutan, Herba Menthae, Chinese medicine honeysuckle, the Paeonia suffruticosa corium farinosum becomes coarse powder, add 8 times of amounts of medical material weight (g) (ml) water, connect volatile oil extractor, reflux condensing tube, put and slowly be heated to boiling in the electric jacket, read different time volatile oil extracted amount, oil mass stops heating when no longer increasing, the results are shown in Table 1.
Table 1 volatile oil extraction time investigation result
3 and 2 hours relatively, and the increase of volatilization oil mass is very slow, so determine that it is 3 hours that volatile oil extracts the receipts oil time.
Because above-mentioned four Chinese medicine material also adopts decocting to extract, so can eight distinguish the flavor of after water carries medical material and mix with other, decocting is collected volatile oil simultaneously.
2. extraction process by water is investigated
Physicochemical property and pertinent literature according to prescription Chinese crude drug effective ingredient, Bombyx mori L., Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Radix Isatidis, Radix Rehmanniae, Radix Glycyrrhizae, Rhizoma Imperatae and Fructus Forsythiae, Cortex Moutan, Herba Menthae, Flos Lonicerae are adopted the decocting method, amount of water, decocting time and decocting number of times, the employing optimization of orthogonal test is selected, adopt four factors, three horizontal quadrature tables, the gauge outfit design sees Table 2.Extraction ratio with peoniflorin in the Radix Paeoniae Rubra serves as to investigate index, and paeoniflorin content adopts high performance liquid chromatography to measure, and experimental technique is as follows:
Get 1/8 recipe quantity, 12 flavor medical materials, amount of water, decocting time and decocting number of times are by the orthogonal table design operation, and the water-bath of 9 groups of experiment extracting solution is concentrated into dried, and drying under reduced pressure is weighed, calculated yield.Precision takes by weighing 1/250 amount respectively, adds 50% dissolve with ethanol, quantitatively is transferred in the 50ml measuring bottle, adds 50% ethanol dilution to scale, shakes up, as need testing solution.Precision takes by weighing the peoniflorin reference substance in addition, adds dissolve with methanol, makes the solution that every 1ml contains 0.05mg, in contrast product solution.
Accurate need testing solution, each the 10 μ l of reference substance solution of drawing of algoscopy, inject chromatograph of liquid, according to high performance liquid chromatography (one one of Chinese Pharmacopoeia version in 2005, appendix VID) test, be mobile phase with methanol-0.05mol/L potassium dihydrogen phosphate (15:85); The detection wavelength is 230nm, measures, and calculates.Orthogonal experiment plan is taken into account interpretation of result and be the results are shown in Table 3,4.
Calculate the percentage composition of peoniflorin in the extract by following formula.
A
Supply: test sample area integral value A
Right: reference substance area integral value
V: test sample constant volume (ml) v: test sample is annotated sample volume (μ l)
W: Radix Paeoniae crude drug amount (mg) V
Right: reference substance is annotated sample volume (μ l)
Table 2 decocting technology four factors three horizontal quadrature table gauge outfits
ANOVA showed significant A, B, C are the significantly factor, and intuitive analysis is the result show, though amount of water, extraction time to the extraction there was no significant difference of peoniflorin, extract to select for use more than 8 times, 6 times and add 10 times of water gagings and extract but add 10 times of water gaging peoniflorins; Extract 3 peoniflorin extracted amounts more than 2 times, 1 time, but consider and extract 2 times, most effective ingredient are proposed selective extraction 2 times, each 1.5 hours.
Table 3 analysis of variance table
F
1-0.10(2,2)=9.16 F
1-0.05(2,2)=19.16 F
1-0.01(2,2)=99.17
Table 4 orthogonal experiment plan is taken into account interpretation of result (* 10
-2)
3. the selection of alcohol precipitation concentration: this product 12 flavor medical material decocting paste-forming rates are about 31.4%, and paste volume more directly feeds intake has solid content to separate out through trial-production, needs to adopt ethanol precipitation to make with extra care, and to guarantee that gel is transparent, no solid content is separated out.Getting three alcohol precipitation concentrations commonly used, serves as to investigate index with paste volume and content of paeoniflorin, and paeoniflorin content adopts high performance liquid chromatography to measure, and experimental technique is as follows:
Get 1/8 recipe quantity medical material, 10 times of water gagings are fried in shallow oil 3 times, and each 1 hour, filter, merging filtrate is concentrated into the clear paste of relative density 1.05~1.08 (50 ℃), puts to be divided into 4 parts after cold.A copy of it drying under reduced pressure (80 ℃ 0.05Mpa), are weighed.Other 3 parts add ethanol respectively, make to contain alcohol amount and be respectively 60%, 70%, 80%, leave standstill, and filter, and filtrate recycling ethanol is not to there being the alcohol flavor, and water-bath is concentrated into dried, drying under reduced pressure (80 ℃ 0.05Mpa), are weighed.Precipitation is weighed after the oven dry respectively.Precision weighing contains 60%, 70%, 80% 3 sample of alcohol amount respectively, adds 50% dissolve with ethanol, quantitatively is transferred in the 50ml measuring bottle, adds 50% ethanol dilution to scale, shakes up, and as need testing solution, carries out paeoniflorin content and measures.The results are shown in Table 5.The result shows, is that 70% precipitate with ethanol effect is best to contain the alcohol amount.
Table 5 precipitate with ethanol result of the test
Contain the alcohol amount | 60% | 70% | 80% | Precipitate with ethanol not |
Precipitation heavy (g) | 11.25 | 14.5 | 17.5 | |
Filtrate evaporate to dryness solid heavy (g) | 30.0 | 26.75 | 23.75 | |
Gross weight (g) | 41.25 | 41,25 | 41.25 | 41.25 |
Paeoniflorin content (%) | 0.60 | 0.90 | 0.82 |
4. alcohol extraction process is investigated
According to the physicochemical property of prescription Chinese crude drug effective ingredient, with reference to the extraction process of Qingjiangpian tablets, Radix Et Rhizoma Rhei, Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae adopt alcohol extraction.Concentration of alcohol, alcohol adding amount, extraction time and extraction time adopt optimization of orthogonal test to select.Adopt four factors, three horizontal quadrature tables, the gauge outfit design sees Table 6.Extraction ratio with emodin, chrysophanol in the Radix Et Rhizoma Rhei serves as to investigate index, and the content of emodin, chrysophanol adopts high performance liquid chromatography to measure, and experimental technique is as follows:
Get 1/10 recipe quantity four Chinese medicine material, concentration of alcohol, alcohol adding amount, extraction time and extraction time are got 9 groups of experiment extracting solution and are got the Radix Et Rhizoma Rhei 150mg amount that is equivalent to respectively by the orthogonal table design operation, be transferred in the 50ml measuring bottle, add methanol and be diluted to scale, shake up, as need testing solution.Precision takes by weighing emodin, chrysophanol reference substance in addition, adds dissolve with methanol, makes the mixed solution that every 1ml contains emodin 5 μ g, chrysophanol 10 μ g respectively, in contrast product solution.
The accurate need testing solution 10 μ l that draw of algoscopy, reference substance solution 10 μ l inject chromatograph of liquid, according to high performance liquid chromatography (one one of Chinese Pharmacopoeia version in 2005, appendix VI D) test, be mobile phase with methanol-0.1% phosphoric acid solution (85:15), the detection wavelength is 254nm, measures, and calculates.
Calculate the content of emodin, chrysophanol in the extracting solution by following formula.The emodin orthogonal experiment plan is taken into account interpretation of result and be the results are shown in Table 7,8, and the chrysophanol orthogonal experiment plan is taken into account interpretation of result and be the results are shown in Table 9,10.
A
Supply: test sample area integral value A
Right: reference substance area integral value
V: test sample constant volume (ml) v: test sample is annotated sample volume (μ l)
W: Radix Et Rhizoma Rhei crude drug amount (mg) V
Right: reference substance is annotated sample volume (μ l)
Table 6 alcohol extraction process four factors three horizontal quadrature table gauge outfits
Table 7 emodin orthogonal experiment plan is taken into account interpretation of result (* 10
-2)
Table 8 emodin analysis of variance table (* 10
-2)
F
1-0.10(2,2)=9.16 F
1-0.05(2,2)=19.16 F
1-0.01(2,2)=99.17
Directly perceived or the variance analysis of emodin shows that all A is the remarkable factor from table, and C, D, B are not the significantly factor, and promptly concentration of alcohol have considerable influence to Radix Et Rhizoma Rhei.Optimum combination A
3B
2C
3D
2Or A
2B
2C
3D
2The variance analysis of chrysophanol shows that all A, B, C, D are not the significantly factor from table, but intuitive analysis is the result show, concentration of alcohol 60%, 80% chrysophanol extraction ratio is approaching, extract 3 times than extract 2 times, 1 time for good, 1.5 hours extraction times and 2 hours are approaching, all are higher than 1 hour.Excellent combination A
2B
2C
3D
2Or A
3B
2C
3D
2So select 8 times of amount 60% or 80% ethanol extractions 3 times, each 1.5 hours.It is higher than 80% ethanol to extract emodin 60% ethanol, the two is approaching to extract chrysophanol, take all factors into consideration other drug such as Indigo Naturalis, Radix Scrophulariae, Semen Gleditsiae (the extraction solvent of Qingjiangpian tablets two flavors is 80% ethanol), so determine 8 times of amount 80% ethanol extractions 3 times, each 1.5 hours.
Table 9 chrysophanol orthogonal experiment plan is taken into account interpretation of result (* 10
-2)
Table 10 analysis of variance table (* 10
-2)
F
1-0.10(2,2)=9.16 F
1-0.05(2,2)=19.16 F
1-0.01(2,2)=99.17
The checking of 80% alcohol extraction number of times
Extract solvent, dosage and extraction time, optimize the result by orthogonal experiment and test, extracts three times, determine extraction time according to the extracted amount of three times paste volumes and emodin, chrysophanol.Emodin, chrysophanol content assaying method are with the investigation of alcohol extraction technology.
Test method: get 1/2 recipe quantity Radix Et Rhizoma Rhei, Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, add 8 times of amount 80% ethanol, extract each 1.5 hours three times.Collect extracting solution respectively, filter, reclaim solvent, water bath method, drying under reduced pressure (0.05Mp, 80 ℃) is weighed.
The preparation of reference substance solution is with alcohol extraction technology.
The preparation of need testing solution precision respectively takes by weighing extract 20mg three times, puts in the round-bottomed flask.Add 8% hydrochloric acid solution 10ml, add chloroform 10ml again, reflux 1 hour.Put coldly, put in the separatory funnel, with a small amount of chloroform washing container, incorporate in the separatory funnel, divide and get chloroform layer, acid solution reuse chloroform extraction 3 times, each 10ml merges chloroform liquid, and decompression and solvent recovery is to doing, residue adds methanol makes dissolving, is transferred in the 10ml measuring bottle, adds methanol to scale, shake up, filter, get subsequent filtrate, promptly.
Accurate respectively reference substance solution 10ul and the need testing solution 20 μ l of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
The investigation result of the test of table 11 80% alcohol extraction number of times
Paste volume (g) | Paste-forming rate (%) | Emodin, chrysophanol total amount (%) | Emodin, chrysophanol (mg/ cup) | |
For the first time | 75.4 | 54.6 | 0.73 | 0.78 |
For the second time | 40.0 | 28.9 | 0.19 | 0.20 |
For the third time | 22.9 | 16.5 | 0.04 | 0.04 |
Conclusion: extract for the first time, for the second time paste volume and account for three total amounts 83.5%, for the first time, the extraction total amount of emodin, chrysophanol accounts for three times and extracts 95.8% of total amount for the second time, extracting secondary proposes most effective ingredient, so determine that extraction time is a secondary, to save the solvent and the energy.
Three, preparations shaping Journal of Sex Research
Fructus Forsythiae, Flos Lonicerae, Cortex Moutan, Herba Menthae Haplocalycis volatile oil extraction process, extraction process by water, alcohol precipitation process and alcohol extraction process are selected through optimization of orthogonal test in the clear pour point depression glue, and stable process conditions is feasible, now carry out preparation prescription design and Study on Forming.
(1) preparation prescription design
This product is a gel, and gel means medicinal substances extract and suitable substrate semisolid that make, the tool gel characteristic or the thick liquid preparation of silk fabric.By the substrate difference, gel can be divided into aqueous gel and oil-base gel.
This product medicinal substances extract polarity is bigger, the suitable aqueous gel substrate of using.Aqueous gel substrate generally is made of water, glycerol, propylene glycol and cellulose derivative, Carmomer and alginate, tragcanth, gelatin, starch etc.
Carrageenan is the natural polysaccharide colloid that extracts from the red algae Sargassum, the chain polymer of being made up of salts such as the calcium of galactose and 3,6 inner ether galactose and sulfuric ester, sodium, potassium, magnesium on the structure.Belong to alginates.
Carrageenan can be brought into play the outstanding effect synergism with locust bean gum, Konjac glucomannan, xanthan gum etc., mixes to use obviously to change its gel characteristic, and the viscosity and the intensity of raising carrageenan make gel trend towards high resilience and excreting water phenomenon alleviates.
The safety of carrageenan is confirmed by FAO (Food and Agriculture Organization of the United Nation) and World Health Organization (WHO).Carrageenan is used widely in food industry and medical industry.
(2) determining of the kind of adjuvant: according to the kind of definite adjuvants such as the properties of colloid chemistry of K-carrageenan, dissolubility, gelling, thickening property, concertedness.
Dissolubility: can dissolve in cold water, dissolution velocity improves in hot water more than 70 ℃, and water is the substrate of gel.
Gelling: in the presence of potassium ion, can generate heat-convertible gel, can add potassium chloride and promote to generate heat-convertible gel.
Thickening property: form the colloidal sol of low-viscosity when concentration is low, near Newtonian fluid, concentration raises and forms high viscosity colloidal sol, then is non-Newtonian fluid.
Concertedness: produce synergism with locust bean gum, Konjac glucomannan, xanthan gum isocolloid, can improve the elasticity and the water-retaining property of gel, determine to add Konjac glucomannan to improve the elasticity and the water-retaining property of gel.
Healthy value: carrageenan has the fundamental characteristics of water soluble dietary fiber, and the carrageenan after the degradation in vivo can form the complex of solubility with fibrin.Can be become CO by big enterobacteria zymolysis
2, H
2, short-chain fatty acid such as biogas and formic acid, acetic acid, propanoic acid, become the energy source of probiotic bacteria
(3) orthogonal test of adjuvant and dosage examination: according to the adjuvant characteristics of gel, in conjunction with the pertinent literature of consulting, determining that carrageenan, Rhizoma amorphophalli powder, potassium chloride, water are main matrix, is the determiner of gel molding.Also comprise white sugar, sweeting agent, antiseptic, essence in all the other adjuvants.Adopt optimization of orthogonal test to select the dosage of above-mentioned main matrix.Adopt four factors, three horizontal quadrature tables, the gauge outfit design sees Table 12.A is carrageenan dosage (tumbler), and B is the Rhizoma amorphophalli powder dosage, and C is the potassium chloride dosage, and D is a gel weight.Amount of water deducts other adjuvant amounts for gel weight.Elasticity and mouthfeel, bleeding (water-retaining property) with gel are the examination index, and above-mentioned investigation index is carried out classification, composed and divide, and compose the branch standard and see Table 13, and the moulding process orthogonal experiment plan is taken into account interpretation of result and be the results are shown in Table 14,15,16,17.
Table 12 moulding process four factors three horizontal quadrature table gauge outfits
The elasticity of table 13 gel, mouthfeel, water-retaining property classification and tax divide standard
Compose and divide | Elasticity and mouthfeel | Water-retaining property |
1 | Elasticity is hard or soft, and mouthfeel is satiny | Difference |
2 | Elasticity is harder or softer | Relatively poor |
3 | Elasticity is moderate, and mouthfeel is moderate | Better |
4 | Elasticity is moderate, and mouthfeel is sliding than Cis | Good |
5 | Elasticity is moderate, and mouthfeel is satiny | Fine |
Table 15 elasticity and mouthfeel analysis of variance table
F
1-0.10(2,2)=9.16 F
1-0.05(2,2)=19.16 F
1-0.01(2,2)=99.17
Table 14 orthogonal experiment plan is taken into account elasticity and mouthfeel interpretation of result
Table 16 orthogonal experiment plan is taken into account the water-retaining property interpretation of result
Table 17 water-retaining property analysis of variance table
F
1-0.10(2,2)=9.16 F
1-0.05(2,2)=19.16 F
1-0.01(2,2)=99.17
Directly perceived or the variance analysis of elasticity, mouthfeel shows all that A, B are and is the remarkable factor from table, and D is the remarkable factor, and promptly the dosage of carrageenan, Rhizoma amorphophalli powder has considerable influence to elasticity, the mouthfeel of clear pour point depression glue, and amount of water takes second place.Optimum combination A
1B
2C
3D
3Or A
1B
3C
3D
3
Directly perceived and the variance analysis of water-retaining property shows that all A, B are the remarkable factor from table, and D is the not remarkable factor, and promptly the dosage of carrageenan, Rhizoma amorphophalli powder has considerable influence to the water-retaining property of clear pour point depression glue.Optimum combination A
2B
1C
3D
3Or A
2B
1C
3D
2
Comprehensive above two result of the tests, for reducing the consumption of carrageenan, the amount of the dosage employing level 2 of carrageenan, Rhizoma amorphophalli powder, the dosage of potassium chloride all adopt the amount of level 2, consider that the diameter of gel needs greater than 3.5cm, and every glass of weight is 17g behind the water so need determine to add.This product extract hardship so the dosage of sucrose adopts 1g, also need add a small amount of cyclamate and carry out flavoring, and when cyclamate was used with sucrose, its sugariness can reach more than 80 times; When using separately, its sugariness is that 10g is equivalent to sucrose 500g.The dosage of sorbic acid first antiseptic dosage 0.5g/kg, essence is according to operation instruction.
The ratio of adjuvant that adopts orthogonal test to determine carries out sample preparation, and the elasticity of sample, mouthfeel, water-retaining property are all very desirable.
Preparation prescription:
(3) preparations shaping technology
12 flavor water extract thick pastes such as Bombyx mori L. mix with alcohol extract thick paste, volatile oil extracting solution, citric acid, potassium chloride, white sugar, cyclamate, antiseptic, are dissolved in water; With carrageenan aqueous solution mixing, add volatile oil, essence, in 70 ℃ of water-baths, heat mixing, packing, sealing is behind the pasteurization, promptly.
Claims (4)
1, a kind of Chinese medicine composition for the treatment of painful swelling of throat and constipation is characterized in that making the raw materials of effective components medicine and consists of:
400 Radix Ophiopogonis 400 of silkworm excrement 400 Radix Et Rhizoma Rhei 400 Radix Scrophulariaes 400 Semen Gleditsiae 400 Radix Paeoniae Rubra
Fructus Forsythiae 400 Radix Isatidis 400 Radix Rehmanniae 400 Flos Loniceraes 400 Rhizoma Imperataes 400
Cortex Moutan 260 Indigo Naturaliss 200 Bulbus Fritillariae Cirrhosaes 200 Herba Menthaes 200 Radix Glycyrrhizaes 132;
Its preparation method is:
More than ten Six-elements, Radix Et Rhizoma Rhei powder is made coarse powder and is mixed with Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, adds 8 times of amount 80% ethanol extractions twice, each 1.5 hours, merge alcohol extract, reclaim ethanol and be condensed into cream, relative density 1.30~11.35,60 ℃;
Cortex Moutan is made coarse powder, with silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae, Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae mixes, adding 10 times of water gagings decocts twice, each 1.5 hours, collect volatile oil, the gradation of water extract filters, merging filtrate, be concentrated into relative density 1.05~11.08,60 ℃, put to room temperature, add ethanol and make that to contain alcohol amount be 70%, standing over night filters filtrate recycling ethanol, be concentrated into relative density 1.25~11.35,60 ℃, thick paste, make plain sheet or coated tablet or thin membrane coated tablet according to appendix rules of preparations of Chinese Pharmacopoeia version in 2000.
2, the Chinese medicine composition of treatment painful swelling of throat and constipation according to claim 1 is characterized in that described Chinese medicine composition is a pour point depression glue clearly, and it is prepared from by following processing step:
A, prescription:
Cortex Moutan, silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis,
Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae,
The water extract 0.703kg of Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae
The ethanol extract 0.37kg of Radix Et Rhizoma Rhei, Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae
The extraction volatile oil 5.5ml of Fructus Forsythiae, Cortex Moutan, Herba Menthae, Flos Lonicerae
Carrageenan 0.3774kg
Rhizoma amorphophalli powder 0.3774kg
Potassium chloride 0.0943kg
Sucrose 3.774kg
Citric acid 0.0566kg
Cyclamate 0.1132kg
Antiseptic 0.0321kg
Water 58.3kg
B, preparation method: feed intake according to the described raw materials of effective components medicine composition that makes of claim 1:
Radix Et Rhizoma Rhei powder is made coarse powder and is mixed with Indigo Naturalis, Radix Scrophulariae, Bulbus Fritillariae Cirrhosae, adds 8 times of amount 80% ethanol extractions twice, and each 1.5 hours, merge alcohol extract, reclaim ethanol and be condensed into cream, relative density 1.30~11.35,60 ℃;
Cortex Moutan is made coarse powder, mix with silkworm excrement, Semen Gleditsiae, Radix Paeoniae Rubra, Radix Ophiopogonis, Fructus Forsythiae, Flos Lonicerae, Radix Isatidis, Radix Rehmanniae, Rhizoma Imperatae, Herba Menthae, Radix Glycyrrhizae, adding 10 times of water gagings decocts twice, each 1.5 hours, collect volatile oil, the gradation of water extract filters, merging filtrate, be concentrated into relative density 1.05 ~ 1.08,60 ℃; Put to room temperature, add ethanol and make that to contain alcohol amount be 70%, standing over night filters, and filtrate recycling ethanol is concentrated into relative density 1.25~11.35,, 60 ℃ thick paste;
Water is proposed thick paste, alcohol extraction thick paste, citric acid, potassium chloride, white sugar, cyclamate, antiseptic mixing, add the water stirring and dissolving; With carrageenan, Rhizoma amorphophalli powder aqueous solution mixing, heating for dissolving in 70 ℃ of water-baths, add volatile oil, essence, add water to 64.2Kg, mixing, packing, sealing is behind the pasteurization, promptly.
3, the clear pour point depression glue that makes of the preparation method of the Chinese medicine composition of treatment painful swelling of throat and constipation as claimed in claim 2 is characterized in that every glass contains emodin (C
15H
10O
5), chrysophanol (C
15H
10O
4) total amount must not be less than the quantitative target of 0.50mg.
4, the clear pour point depression glue that makes of the preparation method of the Chinese medicine composition of treatment painful swelling of throat and constipation as claimed in claim 2 is characterized in that being provided with in the quality standard diagnostic test project of emodin in Radix Paeoniae, Radix Scrophulariae, Flos Lonicerae, Indigo Naturalis and the Radix Et Rhizoma Rhei, chrysophanol assay:
(1) identification of test method of wherein set Radix Paeoniae is: get 1 glass of this product, be cut into small pieces, put in the round-bottomed flask, add 100ml methanol, water-bath backflow 30min filters, water bath method, residue add water 40ml makes dissolving, filters, by the AB-8 macroporous resin column, internal diameter 10~112mm, long 100mm, earlier with water 100ml eluting, discard water lotion, reuse 30% alcoholic solution 100ml eluting continues with 70% alcoholic solution 80ml eluting; 30% ethanol elution evaporate to dryness, residue add methanol 2ml makes dissolving, as need testing solution; Other gets the peoniflorin reference substance, adds methanol and makes dissolving, makes the solution that every 1ml contains 1mg, in contrast product solution; Test according to an appendix VIB of Chinese Pharmacopoeia version in 2005 thin layer chromatography, draw above-mentioned two kinds of solution, 5 μ l respectively, put respectively on same silica gel g thin-layer plate, with chloroform: ethyl acetate: methanol: formic acid=45:5:10:0.2 is developing solvent, launch, take out, dry, spray is with 10 ℅ ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of peoniflorin reference substance chromatograph on, show the speckle of same color;
(2) identification of test method of wherein set Radix Scrophulariae is: get 70% ethanol elution of using of discriminating (1), water bath method, residue add methanol 2ml makes dissolving, as need testing solution; Other gets Radix Scrophulariae control medicinal material powder 2g, adds methanol 10ml, soaks 1 hour, and supersound process 15 minutes filters, and filtrate is product solution in contrast; Test according to thin layer chromatography (appendix VIB of Chinese Pharmacopoeia version in 2005), draw above-mentioned two kinds of solution, 3 μ l respectively, put respectively on same silica gel g thin-layer plate, with n-butyl alcohol: glacial acetic acid: water=7:1:2 is developing solvent, and lamellae launches with developing solvent presaturation 15 minutes, take out, dry, spray is with vanillin sulphuric acid test solution, and hot blast blows to clear spot; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
(3) identification of test method of wherein set Flos Lonicerae is: get the need testing solution of discriminating (1), be need testing solution; Other gets the chlorogenic acid reference substance, adds dissolve with methanol, makes the solution that every 1ml contains 1mg, in contrast product solution; Test according to an appendix VIB of Chinese Pharmacopoeia version in 2005 thin layer chromatography, draw above-mentioned two kinds of solution, 5 μ l respectively, put respectively on same silica gel g thin-layer plate, with butyl acetate: formic acid: water=7:2.5:2.5 is developing solvent, launches, take out, dry, put under the uviol lamp 365nm and inspect, in the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the fluorescence speckle of same color;
(4) identification of test method of wherein set Indigo Naturalis is: get one glass of this product, shred, put in the round-bottomed flask, add chloroform 20ml, water-bath refluxed 10 minutes, filtered, and filtrate is as need testing solution; Other gets the indirubin reference substance, adds chloroform, makes the solution that every 1ml contains 1mg, in contrast product solution; According to thin layer chromatography test, draw each 5 ~ 10ul of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with toluene: chloroform: acetone=5:4:1 is developing solvent, launches, and takes out, and dries; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of identical redness;
(5) emodin in the wherein set Radix Et Rhizoma Rhei, the method for chrysophanol assay are: according to one one of Chinese Pharmacopoeia version in 2005, and appendix VID high effective liquid chromatography for measuring,
Chromatographic condition and system suitability test octadecylsilane chemically bonded silica are filler; Methanol: 0.1% phosphoric acid solution=85:15 is a mobile phase; Flow velocity 1.0ml/min; Detect wavelength 254nm; Column temperature is a room temperature; Number of theoretical plate calculates by the emodin peak should be not less than 2000;
Precision takes by weighing emodin respectively, the chrysophanol reference substance is an amount of in the preparation of reference substance solution, makes the solution that every 1ml contains 6 μ g, 10 μ g, promptly;
One glass of this product is got in the preparation of need testing solution, and accurate the title decides, chopping, put in the apparatus,Soxhlet's, added the methanol reflux 3 hours, put cold, be transferred in the 100ml measuring bottle, add methanol and be diluted to scale, shake up, precision is measured 25ml, puts in the flask, flings to solvent and adds 8% hydrochloric acid solution 10ml, supersound process 2 minutes adds chloroform 10ml again, reflux 1 hour, put coldly, put in the separatory funnel, with a small amount of chloroform washing container, incorporate in the separatory funnel, divide and get chloroform layer, acid solution reuse chloroform extraction 3 times, each 10ml, merge chloroform liquid, decompression and solvent recovery is to doing, and residue adds methanol makes dissolving, be transferred in the 10ml measuring bottle, add methanol to scale, shake up, filter, get subsequent filtrate, promptly;
Accurate respectively reference substance solution and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101511964A CN101461903A (en) | 2007-12-21 | 2007-12-21 | Chinese medicinal composition for treating painful swelling of throat and constipation, and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101511964A CN101461903A (en) | 2007-12-21 | 2007-12-21 | Chinese medicinal composition for treating painful swelling of throat and constipation, and preparation method thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100005423A Division CN101461904A (en) | 2007-12-21 | 2007-12-21 | Method for testing Chinese medicinal composition for treating painful swelling of throat and constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101461903A true CN101461903A (en) | 2009-06-24 |
Family
ID=40802839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101511964A Pending CN101461903A (en) | 2007-12-21 | 2007-12-21 | Chinese medicinal composition for treating painful swelling of throat and constipation, and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101461903A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008667A (en) * | 2010-12-17 | 2011-04-13 | 天津汉普森药业有限公司 | Preparation method for traditional Chinese medicine composition with antibacterium and antiphlogosis efficacies |
CN102485262A (en) * | 2010-12-03 | 2012-06-06 | 天津中新药业集团股份有限公司达仁堂制药厂 | Traditional Chinese medicine composition with characteristics of clearing heat, detoxifying and relieving throat pain as well as its preparation method |
CN102485265A (en) * | 2010-12-03 | 2012-06-06 | 天津中新药业集团股份有限公司达仁堂制药厂 | Traditional Chinese medicine composition for clearing heat, removing toxins, benefiting throat and relieving pain and a preparation method thereof |
CN110354247A (en) * | 2019-08-12 | 2019-10-22 | 马晟利 | A kind of streptocin compound preparation and preparation method thereof for treating thrush |
-
2007
- 2007-12-21 CN CNA2007101511964A patent/CN101461903A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102485262A (en) * | 2010-12-03 | 2012-06-06 | 天津中新药业集团股份有限公司达仁堂制药厂 | Traditional Chinese medicine composition with characteristics of clearing heat, detoxifying and relieving throat pain as well as its preparation method |
CN102485265A (en) * | 2010-12-03 | 2012-06-06 | 天津中新药业集团股份有限公司达仁堂制药厂 | Traditional Chinese medicine composition for clearing heat, removing toxins, benefiting throat and relieving pain and a preparation method thereof |
CN102008667A (en) * | 2010-12-17 | 2011-04-13 | 天津汉普森药业有限公司 | Preparation method for traditional Chinese medicine composition with antibacterium and antiphlogosis efficacies |
CN102008667B (en) * | 2010-12-17 | 2012-06-13 | 天津汉普森药业有限公司 | Preparation method for traditional Chinese medicine composition with antibacterium and antiphlogosis efficacies |
CN110354247A (en) * | 2019-08-12 | 2019-10-22 | 马晟利 | A kind of streptocin compound preparation and preparation method thereof for treating thrush |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101422563B (en) | Traditional Chinese medicine composition for treating wean sphagitis and preparation method and quality control method thereof | |
CN1925864B (en) | Plant-based medicament for the treatment of hepatitis c | |
CN103271875A (en) | Marbofloxacin freeze-dried powder for injection and preparation method and application thereof | |
CN103251844B (en) | For the tablet of cleaning throat and moistening larynx | |
CN101461903A (en) | Chinese medicinal composition for treating painful swelling of throat and constipation, and preparation method thereof | |
CN101461904A (en) | Method for testing Chinese medicinal composition for treating painful swelling of throat and constipation | |
CN101366876A (en) | Traditional Chinese medicine preparation for treating throat irritation and preparation method thereof | |
CN1879688B (en) | Preparation for treating wind-heat type cold, its preparation process and quality control method | |
CN101991744B (en) | Traditional Chinese medicine perfusion agent for treating milk cow endometritis | |
CN100443896C (en) | Medicine for treating urinary system diseases and its quality control method | |
CN101890087A (en) | Composition containing coptis root, rhubarb and baikal skullcap root | |
CN103494928A (en) | Preparation method for compound houttuynia cordata preparation | |
CN103142683B (en) | Be used for the treatment of Chinese medicinal perfusion liquid containing Herba Sophorae alopecuroidis total alkali of bovine mastitis and endometritis and preparation method thereof | |
CN1326536C (en) | Pharmaceutical composition for treating and preventing respiratory tract viral infection, its preparation process and application | |
CN102397333A (en) | Preparation and quality detection method of Yinhuang injection | |
CN103372076A (en) | Medicine for treating diseases caused by propionibacterium acnes and application of sanguisorba officinalis and/or sanguisorba officinalis extract | |
CN101744883B (en) | Chinese medicinal composition preparation and preparation method thereof and quality control method | |
CN100475256C (en) | A Chinese medicinal composition for treating acute and chronic pharyngolaryngitis, and its preparation method | |
CN105535391A (en) | Medicine composition for treating pneumonia | |
CN104771745A (en) | Traditional Chinese medicine composition for treating diarrhea, preparation method and application thereof | |
CN104367633A (en) | Medicine combination with antibacterial and synergically-antibacterial effects, and preparation method and application | |
CN101579432A (en) | Vaginal gel for treating gynecologic diseases, and preparation method thereof | |
CN103251845B (en) | For the compositions of cleaning throat and moistening larynx | |
CN115840005A (en) | Quality detection method of traditional Chinese medicine compound composition | |
CN109820972B (en) | A kind of traditional Chinese medicine composition for treating acne and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090624 |